MCM
CMD

Matarin Capital Management’s Cantel Medical Corporation CMD Stock Holding History

Matarin Capital Management’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,296
Closed -$1.07M – 264
2019
Q3 		$1.07M Buy
14,296
+217
+2% +$18.4K 0.08% 200
2019
Q2 		$1.14M Hold
14,079
– – 0.08% 205
2019
Q1 		$942K Hold
14,079
– – 0.07% 211
2018
Q4 		$1.05M Sell
14,079
-5,828
-29% -$481K 0.08% 200
2018
Q3 		$1.83M Sell
19,907
-62,078
-76% -$5.91M 0.12% 183
2018
Q2 		$8.06M Sell
81,985
-57,323
-41% -$6.41M 0.58% 69
2018
Q1 		$15.5M Buy
139,308
+107,581
+339% +$12.1M 1.16% 7
2017
Q4 		$3.26M Buy
31,727
+23,850
+303% +$2.38M 0.25% 143
2017
Q3 		$742K Buy
7,877
+469
+6% +$37K 0.06% 214
2017
Q2 		$577K Buy
7,408
+2,763
+59% +$208K 0.05% 211
2017
Q1 		$372K Buy
+4,645
New +$369K 0.04% 241
2016
Q3 		– Sell
-4,381
Closed -$301K – 265
2016
Q2 		$301K Sell
4,381
-9,123
-68% -$629K 0.04% 216
2016
Q1 		$964K Buy
13,504
+4,989
+59% +$313K 0.13% 176
2015
Q4 		$529K Buy
+8,515
New +$519K 0.08% 189

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Matarin Capital Management's CMD Position: Q4 2019 in Review

Matarin Capital Management sold out of Cantel Medical Corporation (CMD) in Q4 2019, closing a stake of 14,296 shares — an estimated $1.07M sold.

Matarin Capital Management first reported a position in CMD in Q4 2015 and held it in 14 quarters. The position peaked at $15.5M in Q1 2018. 237 funds tracked by Wall St. Rank hold CMD as of Q4 2019.

  • Matarin Capital Management reported no remaining Cantel Medical Corporation position as of Q4 2019 after selling out during the quarter.
  • Matarin Capital Management sold 14,296 Cantel Medical Corporation shares in Q4 2019, an estimated $1.07M.
  • Matarin Capital Management first reported a position in Cantel Medical Corporation in Q4 2015 and held it in 14 quarters.
  • Matarin Capital Management's Cantel Medical Corporation position peaked at $15.5M in Q1 2018.
  • 237 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q4 2019.

Based on Matarin Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.